Assessment of a-synuclein pathology: A study of the BrainNet Europe consortium

Irina Alafuzoff, Laura Parkkinen, Safa Al-Sarraj, Thomas Arzberger, Jeanne Bell, Istvan Bodi, Nenad Bogdanovic, Herbert Budka, Isidro Ferrer, Ellen Gelpi, Stephen Gentleman, Giorgio Giaccone, Wouter Kamphorst, Andrew King, Penelope Korkolopoulou, Gábor G. Kovács, Sergey Larionov, David Meyronet, Camelia Monoranu, Jodie MorrisPiero Parchi, Efstratios Patsouris, Wolfgang Roggendorf, Danielle Seilhean, Nathalie Streichenberger, Dietmar R. Thal, Hans Kretzschmar

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

To determine the reliability of assessment of a-synucleinimmunoreactive (aS-IR) structures by neuropathologists, 28 evaluators from 17 centers of BrainNet Europe examined current methods and reproducibility of aS-IR evaluation using a tissue microarray (TMA) technique. Tissue microarray blocks were constructed of samples from the participating centers that contained aS-IR structures. Slides from these blocks were stained in each center and assessed for neuronal perikaryal inclusions, neurites, and glial cytoplasmic inclusions. The study was performed in 2 phases. First, the TMA slides were stained with the antibody of the center's choice. In this phase, 59% of the sections were of good or acceptable quality, and 4 of 9 antibodies used performed consistently. Differences in interpretation and categorization of aS-IR structures, however, led to differing results between the laboratories. Prior to the second phase, the neuropathologists participated in a training session on the evaluation of aS-IR structures. Based on the results of the first phase, selected antibodies using designated antigen retrieval methods were then applied to TMA slides in the second phase. When the designated methods of both staining and evaluation were applied, all 26 subsequently stained TMA sections evaluated were of good/acceptable quality, and a high level of concordance in the assessment of the presence or absence of specific aS-IR structures was achieved. A semiquantitative assessment of aS-IR neuronal perikaryal inclusions yielded agreements ranging from 49% to 82%, with best concordance in cortical core samples. These results suggest that rigorous methodology and dichotomized assessment (i.e. determining the presence or absence of aS-IR) should be applied, and that semiquantitative assessment can be recommended only for the cortical samples. Moreover, the study demonstrates that there are limitations in the scoring of aS-IR structures.

Original languageEnglish
Pages (from-to)125-143
Number of pages19
JournalJournal of Neuropathology and Experimental Neurology
Volume67
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Synucleins
Pathology
Antibodies
Inclusion Bodies
Neurites
Neuroglia
Staining and Labeling
Antigens

Keywords

  • A-synuclein
  • BrainNet Europe
  • Immunohistochemistry
  • Interrater reliability
  • Tissue microarray

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)

Cite this

Alafuzoff, I., Parkkinen, L., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., ... Kretzschmar, H. (2008). Assessment of a-synuclein pathology: A study of the BrainNet Europe consortium. Journal of Neuropathology and Experimental Neurology, 67(2), 125-143. https://doi.org/10.1097/nen.0b013e3181633526

Assessment of a-synuclein pathology : A study of the BrainNet Europe consortium. / Alafuzoff, Irina; Parkkinen, Laura; Al-Sarraj, Safa; Arzberger, Thomas; Bell, Jeanne; Bodi, Istvan; Bogdanovic, Nenad; Budka, Herbert; Ferrer, Isidro; Gelpi, Ellen; Gentleman, Stephen; Giaccone, Giorgio; Kamphorst, Wouter; King, Andrew; Korkolopoulou, Penelope; Kovács, Gábor G.; Larionov, Sergey; Meyronet, David; Monoranu, Camelia; Morris, Jodie; Parchi, Piero; Patsouris, Efstratios; Roggendorf, Wolfgang; Seilhean, Danielle; Streichenberger, Nathalie; Thal, Dietmar R.; Kretzschmar, Hans.

In: Journal of Neuropathology and Experimental Neurology, Vol. 67, No. 2, 02.2008, p. 125-143.

Research output: Contribution to journalArticle

Alafuzoff, I, Parkkinen, L, Al-Sarraj, S, Arzberger, T, Bell, J, Bodi, I, Bogdanovic, N, Budka, H, Ferrer, I, Gelpi, E, Gentleman, S, Giaccone, G, Kamphorst, W, King, A, Korkolopoulou, P, Kovács, GG, Larionov, S, Meyronet, D, Monoranu, C, Morris, J, Parchi, P, Patsouris, E, Roggendorf, W, Seilhean, D, Streichenberger, N, Thal, DR & Kretzschmar, H 2008, 'Assessment of a-synuclein pathology: A study of the BrainNet Europe consortium', Journal of Neuropathology and Experimental Neurology, vol. 67, no. 2, pp. 125-143. https://doi.org/10.1097/nen.0b013e3181633526
Alafuzoff, Irina ; Parkkinen, Laura ; Al-Sarraj, Safa ; Arzberger, Thomas ; Bell, Jeanne ; Bodi, Istvan ; Bogdanovic, Nenad ; Budka, Herbert ; Ferrer, Isidro ; Gelpi, Ellen ; Gentleman, Stephen ; Giaccone, Giorgio ; Kamphorst, Wouter ; King, Andrew ; Korkolopoulou, Penelope ; Kovács, Gábor G. ; Larionov, Sergey ; Meyronet, David ; Monoranu, Camelia ; Morris, Jodie ; Parchi, Piero ; Patsouris, Efstratios ; Roggendorf, Wolfgang ; Seilhean, Danielle ; Streichenberger, Nathalie ; Thal, Dietmar R. ; Kretzschmar, Hans. / Assessment of a-synuclein pathology : A study of the BrainNet Europe consortium. In: Journal of Neuropathology and Experimental Neurology. 2008 ; Vol. 67, No. 2. pp. 125-143.
@article{2166e3ed0df741ad85d24d9d750998d9,
title = "Assessment of a-synuclein pathology: A study of the BrainNet Europe consortium",
abstract = "To determine the reliability of assessment of a-synucleinimmunoreactive (aS-IR) structures by neuropathologists, 28 evaluators from 17 centers of BrainNet Europe examined current methods and reproducibility of aS-IR evaluation using a tissue microarray (TMA) technique. Tissue microarray blocks were constructed of samples from the participating centers that contained aS-IR structures. Slides from these blocks were stained in each center and assessed for neuronal perikaryal inclusions, neurites, and glial cytoplasmic inclusions. The study was performed in 2 phases. First, the TMA slides were stained with the antibody of the center's choice. In this phase, 59{\%} of the sections were of good or acceptable quality, and 4 of 9 antibodies used performed consistently. Differences in interpretation and categorization of aS-IR structures, however, led to differing results between the laboratories. Prior to the second phase, the neuropathologists participated in a training session on the evaluation of aS-IR structures. Based on the results of the first phase, selected antibodies using designated antigen retrieval methods were then applied to TMA slides in the second phase. When the designated methods of both staining and evaluation were applied, all 26 subsequently stained TMA sections evaluated were of good/acceptable quality, and a high level of concordance in the assessment of the presence or absence of specific aS-IR structures was achieved. A semiquantitative assessment of aS-IR neuronal perikaryal inclusions yielded agreements ranging from 49{\%} to 82{\%}, with best concordance in cortical core samples. These results suggest that rigorous methodology and dichotomized assessment (i.e. determining the presence or absence of aS-IR) should be applied, and that semiquantitative assessment can be recommended only for the cortical samples. Moreover, the study demonstrates that there are limitations in the scoring of aS-IR structures.",
keywords = "A-synuclein, BrainNet Europe, Immunohistochemistry, Interrater reliability, Tissue microarray",
author = "Irina Alafuzoff and Laura Parkkinen and Safa Al-Sarraj and Thomas Arzberger and Jeanne Bell and Istvan Bodi and Nenad Bogdanovic and Herbert Budka and Isidro Ferrer and Ellen Gelpi and Stephen Gentleman and Giorgio Giaccone and Wouter Kamphorst and Andrew King and Penelope Korkolopoulou and Kov{\'a}cs, {G{\'a}bor G.} and Sergey Larionov and David Meyronet and Camelia Monoranu and Jodie Morris and Piero Parchi and Efstratios Patsouris and Wolfgang Roggendorf and Danielle Seilhean and Nathalie Streichenberger and Thal, {Dietmar R.} and Hans Kretzschmar",
year = "2008",
month = "2",
doi = "10.1097/nen.0b013e3181633526",
language = "English",
volume = "67",
pages = "125--143",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Assessment of a-synuclein pathology

T2 - A study of the BrainNet Europe consortium

AU - Alafuzoff, Irina

AU - Parkkinen, Laura

AU - Al-Sarraj, Safa

AU - Arzberger, Thomas

AU - Bell, Jeanne

AU - Bodi, Istvan

AU - Bogdanovic, Nenad

AU - Budka, Herbert

AU - Ferrer, Isidro

AU - Gelpi, Ellen

AU - Gentleman, Stephen

AU - Giaccone, Giorgio

AU - Kamphorst, Wouter

AU - King, Andrew

AU - Korkolopoulou, Penelope

AU - Kovács, Gábor G.

AU - Larionov, Sergey

AU - Meyronet, David

AU - Monoranu, Camelia

AU - Morris, Jodie

AU - Parchi, Piero

AU - Patsouris, Efstratios

AU - Roggendorf, Wolfgang

AU - Seilhean, Danielle

AU - Streichenberger, Nathalie

AU - Thal, Dietmar R.

AU - Kretzschmar, Hans

PY - 2008/2

Y1 - 2008/2

N2 - To determine the reliability of assessment of a-synucleinimmunoreactive (aS-IR) structures by neuropathologists, 28 evaluators from 17 centers of BrainNet Europe examined current methods and reproducibility of aS-IR evaluation using a tissue microarray (TMA) technique. Tissue microarray blocks were constructed of samples from the participating centers that contained aS-IR structures. Slides from these blocks were stained in each center and assessed for neuronal perikaryal inclusions, neurites, and glial cytoplasmic inclusions. The study was performed in 2 phases. First, the TMA slides were stained with the antibody of the center's choice. In this phase, 59% of the sections were of good or acceptable quality, and 4 of 9 antibodies used performed consistently. Differences in interpretation and categorization of aS-IR structures, however, led to differing results between the laboratories. Prior to the second phase, the neuropathologists participated in a training session on the evaluation of aS-IR structures. Based on the results of the first phase, selected antibodies using designated antigen retrieval methods were then applied to TMA slides in the second phase. When the designated methods of both staining and evaluation were applied, all 26 subsequently stained TMA sections evaluated were of good/acceptable quality, and a high level of concordance in the assessment of the presence or absence of specific aS-IR structures was achieved. A semiquantitative assessment of aS-IR neuronal perikaryal inclusions yielded agreements ranging from 49% to 82%, with best concordance in cortical core samples. These results suggest that rigorous methodology and dichotomized assessment (i.e. determining the presence or absence of aS-IR) should be applied, and that semiquantitative assessment can be recommended only for the cortical samples. Moreover, the study demonstrates that there are limitations in the scoring of aS-IR structures.

AB - To determine the reliability of assessment of a-synucleinimmunoreactive (aS-IR) structures by neuropathologists, 28 evaluators from 17 centers of BrainNet Europe examined current methods and reproducibility of aS-IR evaluation using a tissue microarray (TMA) technique. Tissue microarray blocks were constructed of samples from the participating centers that contained aS-IR structures. Slides from these blocks were stained in each center and assessed for neuronal perikaryal inclusions, neurites, and glial cytoplasmic inclusions. The study was performed in 2 phases. First, the TMA slides were stained with the antibody of the center's choice. In this phase, 59% of the sections were of good or acceptable quality, and 4 of 9 antibodies used performed consistently. Differences in interpretation and categorization of aS-IR structures, however, led to differing results between the laboratories. Prior to the second phase, the neuropathologists participated in a training session on the evaluation of aS-IR structures. Based on the results of the first phase, selected antibodies using designated antigen retrieval methods were then applied to TMA slides in the second phase. When the designated methods of both staining and evaluation were applied, all 26 subsequently stained TMA sections evaluated were of good/acceptable quality, and a high level of concordance in the assessment of the presence or absence of specific aS-IR structures was achieved. A semiquantitative assessment of aS-IR neuronal perikaryal inclusions yielded agreements ranging from 49% to 82%, with best concordance in cortical core samples. These results suggest that rigorous methodology and dichotomized assessment (i.e. determining the presence or absence of aS-IR) should be applied, and that semiquantitative assessment can be recommended only for the cortical samples. Moreover, the study demonstrates that there are limitations in the scoring of aS-IR structures.

KW - A-synuclein

KW - BrainNet Europe

KW - Immunohistochemistry

KW - Interrater reliability

KW - Tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=41949092490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949092490&partnerID=8YFLogxK

U2 - 10.1097/nen.0b013e3181633526

DO - 10.1097/nen.0b013e3181633526

M3 - Article

C2 - 18219257

AN - SCOPUS:41949092490

VL - 67

SP - 125

EP - 143

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 2

ER -